Computational identification of specific genes for glioblastoma stem-like cells identity
Open Access
- 17 May 2018
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 8 (1) , 1-10
Abstract
Glioblastoma, the most malignant brain cancer, contains self-renewing, stem-like cells that sustain tumor growth and therapeutic resistance. Identifying genes promoting stem-like cell differentiation might unveil targets for novel treatments. To detect them, here we apply SWIM – a software able to unveil genes (named switch genes) involved in drastic changes of cell phenotype – to public datasets of gene expression profiles from human glioblastoma cells. By analyzing matched pairs of stem-like and differentiated glioblastoma cells, SWIM identified 336 switch genes, potentially involved in the transition from stem-like to differentiated state. A subset of them was significantly related to focal adhesion and extracellular matrix and strongly down-regulated in stem-like cells, suggesting that they may promote differentiation and restrain tumor growth. Their expression in differentiated cells strongly correlated with the down-regulation of transcription factors like OLIG2, POU3F2, SALL2, SOX2, capable of reprogramming differentiated glioblastoma cells into stem-like cells. These findings were corroborated by the analysis of expression profiles from glioblastoma stem-like cell lines, the corresponding primary tumors, and conventional glioma cell lines. Switch genes represent a distinguishing feature of stem-like cells and we are persuaded that they may reveal novel potential therapeutic targets worthy of further investigation.Keywords
This publication has 89 references indexed in Scilit:
- An Aberrant Transcription Factor Network Essential for Wnt Signaling and Stem Cell Maintenance in GlioblastomaCell Reports, 2013
- Impact of therapy on quality of life, neurocognitive function and their correlates in glioblastoma multiforme: a reviewJournal of Neuro-Oncology, 2011
- The intricate mechanisms of neurodegeneration in prion diseasesTrends in Molecular Medicine, 2011
- Pluripotency and Cellular Reprogramming: Facts, Hypotheses, Unresolved IssuesCell, 2010
- Molecular pathology in adult gliomas: diagnostic, prognostic, and predictive markersThe Lancet Neurology, 2010
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trialThe Lancet Oncology, 2009
- Prostate cancer stem cellsThe Journal of Pathology, 2008
- Gene expression profile analysis of primary glioblastomas and non-neoplastic brain tissue: identification of potential target genes by oligonucleotide microarray and real-time quantitative PCRJournal of Neuro-Oncology, 2008
- Neural stem cell self-renewalCritical Reviews in Oncology/Hematology, 2008
- Olig2-Regulated Lineage-Restricted Pathway Controls Replication Competence in Neural Stem Cells and Malignant GliomaNeuron, 2007